NCT02397473 A Study Of Galcanezumab In Participants With Episodic Cluster Headache Status COMPLETED Phase PHASE3
NCT02392507 A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC Status COMPLETED Phase PHASE2
NCT02387814 A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment Status COMPLETED Phase PHASE1
NCT02387801 A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis Status COMPLETED Phase PHASE3
NCT02377752 A Study of Olaratumab in Japanese Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02370485 A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children Status COMPLETED Phase PHASE1
NCT02367131 Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02365558 A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants Status COMPLETED Phase PHASE1
NCT02359058 A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer Status COMPLETED Phase PHASE1
NCT02349295 A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02346344 Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02340104 A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants Status COMPLETED Phase PHASE1
NCT02337387 A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women Status TERMINATED Phase PHASE1
NCT02335346 An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480) Status COMPLETED Phase PHASE3
NCT02327286 Randomized Clinical Trial of Lifestyle Interventions to Prevent Diabetes in Women With Previous Gestational Diabetes Status COMPLETED Phase NA
NCT02326025 A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma Status COMPLETED Phase PHASE1